Skip to main content

What the FDA labels say about taking them together

Clonidine and insulin glulisine

Insulin glulisine's FDA label of November 25, 2025 names clonidine in its drug interactions section; the clonidine labels PlainMeds reads (4) do not name insulin glulisine. The insulin glulisine label: “Drugs that May Increase or Decrease the Blood Glucose Lowering Effect of APIDRA Drugs: Alcohol, beta-blockers, clonidine, and lithium salts.”

Check it at the source: the clonidine FDA label on DailyMed (effective March 30, 2026, Unichem Pharmaceuticals (USA), Inc.); the insulin glulisine FDA label on DailyMed (effective November 25, 2025).

What does the clonidine label say about insulin glulisine?

Clonidine's label (effective March 30, 2026) and its 3 other brand-application labels do not name insulin glulisine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (clonidine hydrochloride), Unichem Pharmaceuticals (USA), Inc., effective March 30, 2026 (SPL set 21bfa28f-20df-43fd-bb80-b720d3b40696), via openFDA; the full label on DailyMed

What does the insulin glulisine label say about clonidine?

Insulin glulisine label, drug interactions

Drugs that May Increase or Decrease the Blood Glucose Lowering Effect of APIDRA Drugs: Alcohol, beta-blockers, clonidine, and lithium salts.

Source: FDA drug label (Apidra), sanofi-aventis U.S. LLC, effective November 25, 2025 (SPL set e7af6a7a-8046-4fb4-9979-4ec4230b23aa), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

43Clonidine generic labelers
0Insulin glulisine generic labelers
ClonidineInsulin glulisine
Labeled forHigh blood pressure, ADHD, PainType 2 diabetes, Type 1 diabetes
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0241 per tablet 0.1 mg tablet$8.16 per mL 100 unit/mL vial
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?